Compare AT&T Inc. (T) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AT&T Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? AT&T Inc. trades at $23.09 (market cap $156.58B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: AT&T Inc. is far larger — about 87× Vir Biotechnology Inc. Common Stock's market cap, and AT&T Inc. pays a 4.86% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold AT&T Inc. for 118 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| T | VIR | |
|---|---|---|
Market Cap | $156.58B | $1.80B |
Volume | 46,597,672 | 1,782,836 |
Sector | Media | Health |
52-Week High | $29.10 | $11.78 |
52-Week Low | $20.49 | $5.12 |
Typical Hold Time | 118 Days | 0 Days |
Enterprise Value | $301.90B | $1.36B |
Dividend Yield | 4.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AT&T (T) trades at $23.08, up 2.62% today, with strong fundamentals including a P/E of 7.54 and net income margin of 16.94%. Recent earnings beat expectations, with Q2 2026 EPS of $0.65 versus $0.59 expected. Technical indicators show a bearish overall signal despite bullish oscillators. The company maintains robust cash flow with $15.12B net cash flow in 2025 and recently announced a $3B fiber deal with Corning to support AI infrastructure growth.
Outlook remains mixed with analyst consensus price target of $27.39 offering 19% upside potential, though technical weakness and competitive pressures pose risks. The stock's 4% dividend yield provides income support, but debt levels and legacy revenue declines require monitoring. Fiber expansion and wireless growth present opportunities amid challenging market conditions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
